Norovirus has surged this winter, causing severe gastrointestinal symptoms including diarrhea and vomiting. Unlike other infections, no vaccine is available. Researchers are actively developing around seven candidates, but effectiveness issues persist. The virus is highly transmissible and resilient, often persisting on surfaces for up to two weeks, evading common disinfectants. Limited CDC data suggests an alarming rise in cases, especially in communal settings like cruise ships and cafeterias, with a significant risk of dehydration among infected individuals. The need for effective vaccine solutions is pressing, as outbreaks remain challenging to manage.
Norovirus is responsible for more than half of foodborne illness cases in the U.S., causing sudden gastrointestinal symptoms with no current vaccine available.
Researchers are hopeful that new approaches in vaccine development may soon provide an effective tool against norovirus, which remains notoriously difficult to combat.
Collection
[
|
...
]